Lineage Cell Therapeutics, Inc.

8-K Shareholder vote results; Other events Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Other events Mar 11, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Other events Nov 28, 2025 8-K Other events Nov 24, 2025 8-K Other events Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Regulation FD disclosure; Other events Aug 26, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Director or officer change; Shareholder vote results Jul 2, 2025 8-K Regulation FD disclosure; Other events Jun 23, 2025 8-K Changed accountants Jun 9, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Other events May 1, 2025 10-K Fiscal year ended 2024-12-31 Mar 10, 2025 8-K Results of operations (earnings release) Mar 10, 2025 8-K Shareholder vote results; Regulation FD disclosure; Other events Jan 27, 2025 8-K Entered a material agreement; Regulation FD disclosure; Other events Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Changed accountants Jun 14, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 13, 2024 8-K Other events May 14, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Entered a material agreement; Other events Mar 22, 2024 10-K Fiscal year ended 2023-12-31 Mar 7, 2024 8-K Results of operations (earnings release) Mar 7, 2024 8-K Other events Feb 15, 2024 8-K Entered a material agreement; Other events Feb 6, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023